|
End-of-day quote
Korea S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 4,705.00 KRW | +11.49% |
|
-13.99% | -31.61% |
| 21/09 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| 14/08 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16Cr | - | - | - | - | - |
| 6.9TCr | |||||
| 5.31TCr | |||||
| 5.08TCr | |||||
| 4.46TCr | |||||
| 4.06TCr | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
